Industry Insights

  1. Applying Appropriate Limits In Cleanroom Monitoring 6/18/2024

    Explore ISO 14644-1:2015 and EU GMP Annex 1 in-depth, and learn about cleanroom classification, how to apply monitoring limits in cleanroom environments, and more.

  2. Will Genome Modifications Define Next-Gen AAV Vectors? 5/20/2025

    AAV vectors composed of naturally occurring capsids are suboptimal. Gentle genetic alterations hold promise for safer, more efficient therapy.

  3. Demystifying Custom Media Development 9/13/2023

    Explore four of the most common concerns surrounding custom media development, and how you can avoid potential challenges and get the most from custom formulations.

  4. Building A Broad Oncology Portfolio With SOTIO CEO Dr. Radek Špíšek

    Establishing an organization that can manage a diverse development pipeline for oncology therapies requires an equally diverse wealth of expertise.

  5. A "Particular" Problem For Cell Therapy Products, Part 2: Cell Clumps And Other Inherent Particles 10/17/2024

    Cell clumps may be present prior to administration of your final drug product. In the absence of regulatory guidance, we recommend establishing a risk management strategy for control of particulates.

  6. Data Management: 5 Best Practices For Emerging Biotechs 2/14/2022

    Whether your ambitious upcoming pharma startup or biotech has its sights set on being the world’s first in your field, or a lucrative exit through a strategic company sale, starting out with good data management practices will set you up for success for the future you envision.

  7. Futurizing Healthcare By Localizing The Life Sciences 12/12/2024

    Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.

  8. Changing Perceptions On Bioprocess Intensification, Continuous Processing 3/1/2021

    Process intensification and continuous bioprocessing are concepts with inconsistent definitions. What's included often varies greatly and, in some ways, has become more about aspirational goal-setting than actual innovation adoption. Here, BioPlan Associates assesses the changing perspectives of 122 bioprocess decision-makers.

  9. Improving Biomanufacturing Resilience In An Uncertain Future 4/28/2022

    Three experts discuss the role and value of collaborations and what strategies can be used to help improve biomanufacturing resilience in an unpredictable but promising future.

  10. Full Control: Binary Blend Feeding A Liquid Chromatography Process, Pt. 2 3/25/2021

    Learn about how booster modules can address pressure variation challenges that disrupt automated blending systems in liquid chromatography processes.